The Federal Trade Commission adopted a final rule Wednesday that will require businesses to make it easy for consumers to cancel unwanted subscriptions.
A San Diego biotech firm hopes Neffy, a nasal spray to counter severe allergic reactions, will encourage those fearing injections to treat anaphylaxis sooner.